A CHEAP supplement could mimic the benefits of exercise, boosting your heart health and metabolism, a new study suggests.

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Data from 32 studies concluded that the impact of exercise is modest in terms of meaningful weight loss. Caloric restriction ...

RuPaul’s Drag Race' star Ginger Minj tells PEOPLE how she lost 160 pounds with Zepbound, why it’s not “the easy way out,” and ...

Are vibration plates another fitness fad, or can they be an effective tool for weight loss? We spoke with fitness experts to ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Confused about whether cardio or weights is better for losing fat? Discover what the latest research says about burning fat, ...

In a conversation that spanned everything from isometrics to internal hip rotation, strength coaches Cory Schlesinger and Zack Zillner dig in on Power Athlete R ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Ethan Noblesala’s doctor said his weight meant he’d need medication and surgery to treat health problems. He’s playing ...